Reata Pharmaceuticals Inc (NASDAQ:RETA)
| 89.38 BATS BZX Real-Time Price As of 10:04am ET |  +1.00 / +1.13%Today’s Change | 18.47 Today|||52-Week Range 95.00 | +135.27% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 2 2018 | Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | |||
| Revenue and Income | Net Revenues | 7.6M | 5.2M | 8.5M | 7.8M | |
| Depreciation And Amortization | 105.0K | 105.0K | 120.0K | 170.0K | ||
| Operating Expenses | Gross Income | -- | -- | -- | -- | -- |
| General Expenses | 34.1M | 34.6M | 33.3M | 36.2M | ||
| Research And Development | 23.4M | 27.1M | 25.3M | 26.1M | ||
| Total Operating Expenses | 34.2M | 34.7M | 33.4M | 36.3M | ||
| Non-Operating Expenses | Operating Income | -26.7M | -29.6M | -24.9M | -28.6M | |
| Extraordinary Charge | -1.0M | 0.00 | 0.00 | 0.00 | ||
| Interest Expense On Debt | 903.0K | 2.4M | 2.4M | 2.4M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -28.2M | -30.8M | -25.6M | -29.2M | |
| Income Taxes | -6.0K | -9.0K | -11.0K | -2.0K | ||
| Net Income | -28.2M | -30.8M | -25.6M | -29.2M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 26.2M | 28.7M | 29.7M | 29.8M | |
| Shares To Calculate EPS Diluted | 26.2M | 28.7M | 29.7M | 29.8M | ||
| Earnings Per Share | EPS | -$1.08 | -$1.07 | -$0.86 | -$0.98 | |
| EPS Diluted | -$1.08 | -$1.07 | -$0.86 | -$0.98 | ||
